CHPA Weighs In As Prop 65 Amicus Brief Filed In Calif. Supreme Court
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association's amicus curiae brief in defense of nicotine-replacement therapy manufacturers involved in California Prop 65 litigation reflects the group's concern the labeling conflict involved could extend to other OTC drugs